drugset / Trial / NCT02679573
Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of delafloxacin compared to moxifloxacin in the treatment of adult patients with community-acquired pneumonia.
Timeline
- Start
- 2016-12-14
- Primary completion
- 2018-07-31
- Completion
- 2018-08-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Delafloxacin | Small molecule | 450 mg | Intravenous |
| Comparator | Linezolid | Other / unclassified | 600 mg | Intravenous |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Intravenous |